
siPSMA-14 R&D Grade
Labelling of radiopharmaceuticals that comprise of such a SiFA group can be produced with isotopic exchange at room temperature.
siPSMA-14 (R&D)
General Information
Product/Article No: 50138
Product name: siPSMA-14
Sequence: L-Glu-urea-L-Glu{D-Orn[Suc-ε-D-Lys-D-Dap(SiFA)-D-Cit-γ-L-Glu-urea-L-Glu]}
Molecular Weight: 1472.6 g/mol (av.)
Molecular Formula: C61H94N13O26SiF
Product description
Labelling of radiopharmaceuticals that comprise of such a SiFA group can be produced with isotopic exchange at room temperature.
For use by qualified personnel only.
For research use only.
Quantity
Product No. 50138: 150nmol; TFA-salt
Packaging
2 mL ISO clear type I tubular glass vials (2R borosilicate clear glass vials type I);
13mm crimp neck;
Lyophilisation stoppers;
Flip-off seal.
Storage and Stability
Storage at – 20°C (± 5 °C) sealed storage, away from moisture and protected from light.
Certificates
Certificate of Quality.
Literature
Loeffler J. et al. (2022) Blocking Studies to Evaluate Receptor-Specific Radioligand Binding in the CAM Model by PET and MR Imaging, Cancers, 2022, 14 (16), 3870
Loeffler, J. et al. (2021) Comparison of Quantification of Target-Specific Accumulation of [18F]F-siPSMA-14 in the HET-CAM Model and in Mice Using PETMRI, Cancers, 2021, 13 (16), 4007